Peter Attia· MD
the mechanism by which it prevents respiratory tract infections is upregulation of an interferon-stimulated antiviral gene response
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
the mechanism by which it prevents respiratory tract infections is upregulation of an interferon-stimulated antiviral gene response
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
so your view is that the the benefit is coming when they're on drug not post washout exactly there may be some benefit post washout but we saw that in the phase 2a in the phase 2b we didn't have enough events after they stopped taking drug because the season was over so i'm where i'm most confident is while they're on drug